SE397474B - Forfarande for utvinning av ett protrombinkomplex innehallande koaguleringsfaktorer - Google Patents

Forfarande for utvinning av ett protrombinkomplex innehallande koaguleringsfaktorer

Info

Publication number
SE397474B
SE397474B SE7008429A SE842970A SE397474B SE 397474 B SE397474 B SE 397474B SE 7008429 A SE7008429 A SE 7008429A SE 842970 A SE842970 A SE 842970A SE 397474 B SE397474 B SE 397474B
Authority
SE
Sweden
Prior art keywords
protrombin
extracting
procedure
complex containing
coagulation factors
Prior art date
Application number
SE7008429A
Other languages
English (en)
Inventor
L F Fekete
E Shanbrom
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of SE397474B publication Critical patent/SE397474B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE7008429A 1969-06-19 1970-06-17 Forfarande for utvinning av ett protrombinkomplex innehallande koaguleringsfaktorer SE397474B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83488369A 1969-06-19 1969-06-19

Publications (1)

Publication Number Publication Date
SE397474B true SE397474B (sv) 1977-11-07

Family

ID=25268043

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7008429A SE397474B (sv) 1969-06-19 1970-06-17 Forfarande for utvinning av ett protrombinkomplex innehallande koaguleringsfaktorer

Country Status (13)

Country Link
US (1) US3560475A (sv)
BE (1) BE751667A (sv)
CA (1) CA920058A (sv)
DE (1) DE2029455C3 (sv)
DK (1) DK127676B (sv)
ES (1) ES380950A1 (sv)
FR (1) FR2052987B1 (sv)
GB (1) GB1253339A (sv)
IL (1) IL34599A (sv)
IT (1) IT1043810B (sv)
NL (1) NL170150C (sv)
SE (1) SE397474B (sv)
ZA (1) ZA703574B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
JPH0686385B2 (ja) * 1980-01-28 1994-11-02 バクスタ−、インタ−ナショナル、インコ−ポレイテッド 活性プロトロンビン複合体組成物およびその製造方法
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
USRE38431E1 (en) * 1995-12-01 2004-02-17 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
JP3944267B2 (ja) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US5770705A (en) * 1996-11-01 1998-06-23 Shanbrom Technologies Llc Method for recovering proteins from plasma using insoluble, water-absorbing material
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
DE602005024955D1 (de) 2004-03-19 2011-01-05 Baxter Healthcare Sa Faktor ixa zur behandlung von blutungsstörungen
CN116194080A (zh) 2020-09-23 2023-05-30 奥姆里克斯生物药品有限公司 止血制剂及其用途

Also Published As

Publication number Publication date
ES380950A1 (es) 1972-10-16
NL170150B (nl) 1982-05-03
NL170150C (nl) 1982-10-01
IL34599A (en) 1973-07-30
US3560475A (en) 1971-02-02
IL34599A0 (en) 1970-07-19
DK127676B (da) 1973-12-17
FR2052987A1 (sv) 1971-04-16
DE2029455B2 (de) 1978-08-24
ZA703574B (en) 1971-01-27
IT1043810B (it) 1980-02-29
DE2029455A1 (de) 1971-02-25
GB1253339A (en) 1971-11-10
CA920058A (en) 1973-01-30
BE751667A (fr) 1970-11-16
FR2052987B1 (sv) 1974-05-24
DE2029455C3 (de) 1979-04-19
NL7008957A (sv) 1970-12-22

Similar Documents

Publication Publication Date Title
SE397474B (sv) Forfarande for utvinning av ett protrombinkomplex innehallande koaguleringsfaktorer
CH538916A (de) Schneidverfahren
DK146868C (da) Navigationsanlaeg for et fartoej
DE2039897B2 (de) Zentrifuge
SE390736B (sv) Forfarande for framstellning av maltos
RO58861A2 (ro) Procedeu de preparare a unor beta-aril-2-aminoalcoxistireni
YU36509B (en) Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers
FI49573C (sv) Packningsmaskin
IT1043806B (it) Procedimento per preparare cinnamamidi sostituite
FI54287B (fi) Foerfarande foer rening av raoaceton
SU505349A3 (ru) Способ получени нафтилалкиламинов
AT310634B (de) Vorrichtung zum Herstellen von Zigaretten
CH509149A (de) Vorrichtung zur Herstellung von Tabletten
BE775509A (fr) Machine a fumer
BE750656A (fr) Dialyseur
FI53582C (fi) Foerfarande foer framstaellning av ett laminatmaterial bestaoende av ett fenolformaldehydhartsskum och ett fiberhaltigt taeckskikt
CH509200A (de) Umwickelmaschine
CH518741A (de) Automatisierte Zentrifugeneinrichtung
FI54584C (fi) Hastighetsbestaemmande anordning foer ett regleringssystem foer en hissmotor
TR16808A (tr) Vakumlu doener doekuem makinesi
FI47498C (sv) Förfarande för framställning av en pepsininhibitor kallad pepstatin
CH532510A (fr) Couvercle
TR16965A (tr) Safe p-ksiloluen kazanilmasina mahsus usul
FI53544C (fi) Loesningsmedel foer ett traeimpregneringsmedel
FI55309C (fi) Tillplattnings- och draganordning foer medelst blaosningsfoerfarande i ett stationaert anordnat blaosningshuvud tillverkad slangformad plastfoliebana